WELCOME
Zealand Pharma's Field Medical Affairs Team Training
This portal supports your essential role in advancing obesity care. This continuing professional development program strengthens your command of clinical data, emerging science, and the full obesity care model—grounded in the International Obesity Collaborative’s five principles—so you can effectively engage healthcare providers and cultivate key opinion leaders during the pre‑launch and post‑launch phases of obesity pharmacotherapies. Powered by TOS’s world‑class faculty and a blended learning approach that integrates didactic, collaborative, and experiential methods, this program is designed to enhance your competence, confidence, and real‑world impact as you help improve outcomes for people living with obesity.
This portal supports your essential role in advancing obesity care. This continuing professional development program strengthens your command of clinical data, emerging science, and the full obesity care model—grounded in the International Obesity Collaborative’s five principles—so you can effectively engage healthcare providers and cultivate key opinion leaders during the pre‑launch and post‑launch phases of obesity pharmacotherapies. Powered by TOS’s world‑class faculty and a blended learning approach that integrates didactic, collaborative, and experiential methods, this program is designed to enhance your competence, confidence, and real‑world impact as you help improve outcomes for people living with obesity.
The Primary Goal of TOS’s Medical Affairs Training:
Equip medical affairs teams with a strong command of clinical data and emerging science, enabling them to communicate the evidence supporting obesity treatments clearly and accurately.
This program supports effective engagement with healthcare providers across the full obesity care model, grounded in the International Obesity Collaborative’s five principles:
Modules
Module 1:
OVERVIEW:
This session aims to deepen understanding of obesity-related bias and stigma in healthcare by helping participants recognize and reflect on their own biases related to weight, body habitus, and perceived causes of obesity. It focuses on identifying how bias and stigma can influence treatment decisions made by both patients and healthcare providers and examines the broader consequences of obesity-related bias on healthcare behaviors, access, and outcomes. The session also emphasizes effective, respectful communication strategies that healthcare professionals can use in clinical and professional settings to reduce bias and promote equitable, patient-centered care for individuals with obesity.
EVALUATIONS:
STEP 1: Taking the Harvard Implicit Association Test (IAT) helps individuals identify hidden, automatic preferences and stereotypes they may not consciously recognize. The test serves as a tool for self-reflection, education, and the initiation of conversations about unconscious bias. While the test is not a perfect diagnostic tool for predicting behavior, it provides valuable, sometimes surprising, insights into societal influences and personal attitudes. Click ‘I wish to proceed‘ and then select ‘Weight IAT‘.
RESOURCES:
Module 1 Recording:
Town Hall Meeting 1/30/26:
Dr. Angela Golden and Joe Nadglowski discuss patient perspectives on bias and stigma and answer questions from the team.
